Abeona Therapeutics Inc
NASDAQ:ABEO
During the last 3 months Abeona Therapeutics Inc insiders have not bought any shares, and sold 141k USD worth of shares. The stock price has dropped by 2% over this period (open performance analysis).
The last transaction was made on
Mar 31, 2025
by
Seshadri Vishwas
(Chief Technology Officer)
, who
sold
119.5k USD
worth of ABEO shares.
During the last 3 months Abeona Therapeutics Inc insiders have not bought any shares, and sold 141k USD worth of shares. The stock price has dropped by 2% over this period (open performance analysis).
The last transaction was made on
Mar 31, 2025
by
Seshadri Vishwas
(Chief Technology Officer)
, who
sold
119.5k USD
worth of ABEO shares.
Abeona Therapeutics Inc
Glance View
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. The company is headquartered in New York City, New York and currently employs 90 full-time employees. The Company’s lead clinical programs consist of EB-101, which is an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102, which is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101, which is an AAV-based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company is focused on to develop additional AAV-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that has a license from the University of North Carolina at Chapel Hill and internal AAV vector research programs.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet